ClinicalTrials.Veeva

Menu

Effects of Aerobic Versus Resistance Training on Bone Metabolism in Stage 3-4 Chronic Kidney Disease (CKD-BONE-EX)

S

Sinai University

Status

Completed

Conditions

Osteopenia
Bone Metabolism Disorders
Chronic Kidney Disease (Stage 3-4)
Mineral and Bone Disorder (CKD-MBD)

Treatments

Behavioral: Resistance Exercise
Behavioral: Aerobic Training

Study type

Interventional

Funder types

Other

Identifiers

NCT07133256
SU.REC.2025(45H)

Details and patient eligibility

About

This randomized controlled trial investigates the comparative effects of aerobic versus resistance training on bone mineral density (BMD) and bone metabolism markers in patients with stage 3 or 4 chronic kidney disease (CKD). The primary aim is to evaluate the impact of two distinct exercise modalities on serum osteoprotegerin (OPG), receptor activator of nuclear factor kappa-B ligand (RANKL), and the OPG/RANKL ratio, as well as densitometric changes at key skeletal sites.

Full description

Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a common complication in non-dialysis CKD patients, driven by disrupted calcium-phosphate metabolism, secondary hyperparathyroidism, and altered bone remodeling pathways, such as the OPG-RANKL axis. Exercise is an emerging non-pharmacological strategy to mitigate skeletal deterioration in CKD, yet the differential effects of aerobic and resistance training on bone health remain poorly understood in this population.

This study recruited 60 CKD patients (stage 3-4, aged 30-50 years) and randomly allocated them into two groups (n=30 each): a resistance training group and an aerobic exercise group. Both groups underwent supervised exercise 3 times per week for six months. Bone mineral density was assessed using dual-energy X-ray absorptiometry (DEXA) at the lumbar spine (L2-L4), femoral neck, and distal radius. Serum concentrations of OPG and RANKL were measured via ELISA at baseline and post-intervention.

Enrollment

60 patients

Sex

All

Ages

30 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 30 to 50 years
  • Diagnosed with stage 3 or 4 chronic kidney disease (non-dialysis dependent)
  • BMI between 20 and 24 kg/m²
  • Not currently taking medications that affect bone density (e.g., corticosteroids, bisphosphonates)
  • Non-smokers and abstinent from alcohol
  • Not receiving hormone replacement therapy
  • Willing and able to participate in supervised exercise sessions for 6 months

Exclusion criteria

  • Diagnosis of type 1 diabetes mellitus
  • Uncontrolled hypertension
  • History of cardiovascular, musculoskeletal, endocrine, or metabolic bone disease
  • Pregnant or planning pregnancy during the study period
  • Participation in a structured exercise program within the last 3 months
  • Contraindications to exercise as determined by medical evaluation
  • Use of investigational drugs or enrollment in another clinical trial during the study period

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Resistance Exercise Group (Group A)
Experimental group
Description:
Participants in this arm engaged in supervised resistance training three times per week for six months. Each session included: 5-minute warm-up with dynamic stretching and range-of-motion exercises 30-minute resistance training using weight machines targeting major muscle groups (upper limbs, lower limbs, and trunk) Intensity: 60% to 80% of one-repetition maximum (1-RM), adjusted progressively 10-minute cool-down with static stretching Sessions were monitored by trained physiotherapists.
Treatment:
Behavioral: Resistance Exercise
Aerobic Exercise Group (Group B)
Active Comparator group
Description:
Participants in this arm performed supervised aerobic exercise (treadmill walking) three times per week for six months. Each session included: 5-minute warm-up 30-minute treadmill walking at 60%-80% of age-predicted maximum heart rate (HRmax = 220 - age) 10-minute cool-down Exercise sessions were supervised by trained exercise professionals and tailored to maintain target heart rate zones.
Treatment:
Behavioral: Aerobic Training

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems